Chronic NF-κB activation in HBV-related HCC is linked to poorer prognoses and increased tumor burden, underscoring the role of inflammation in HBV-driven oncogenesis (Sivasudhan et al., 2022). The gene discussed is NFKB1; the disease is neoplasm.